Wang Yongyan

[Expert Profile] Wang Yongyan, Chief Physician, Professor, Doctoral Supervisor, Academician of the Chinese Academy of Engineering, National Master of Chinese Medicine, is an authoritative expert in TCM encephalopathy in China, working at the China Academy of Chinese Medical Sciences. He has long been dedicated to clinical diagnosis, treatment, and scientific research of TCM encephalopathy, stroke, and senile dementia, and is an important founder of modern TCM encephalopathy discipline.

[Education & Career] Professor Wang Yongyan graduated from Beijing College of Traditional Chinese Medicine (now Beijing University of Chinese Medicine), studied under TCM masters such as Dong Jianhua, and has long been engaged in TCM encephalopathy clinical and research work. He has served as President of Beijing University of Chinese Medicine and President of the China Academy of Chinese Medical Sciences. He was elected as an Academician of the Chinese Academy of Engineering in 1997, received the title of "National Master of Chinese Medicine" in 2017, and is an important academic leader in TCM encephalopathy and TCM internal medicine in China.

[Areas of Expertise] Professor Wang specializes in comprehensive TCM treatment and rehabilitation of ischemic stroke, TCM treatment of vascular dementia and senile dementia, as well as syndrome differentiation and treatment of various encephalopathy and internal medicine difficult miscellaneous diseases. He has profound expertise in the application of therapeutic methods such as "resolving phlegm and unblocking the bowels" during the acute stroke phase, as well as the integration of TCM rehabilitation with modern rehabilitation. He excels at managing difficult encephalopathy patients with "post-stroke sequelae and cognitive impairment," helping numerous patients improve neurological function and slow dementia progression.

[Academic Achievements & Industry Contributions] Professor Wang has led a series of clinical studies on TCM treatment of stroke and dementia, systematically verifying the efficacy of Chinese herbal compound formulas and TCM characteristic therapies, with findings published in authoritative domestic and international journals. He has authored authoritative monographs such as TCM Encephalopathy, led the development of multiple TCM encephalopathy diagnosis and treatment guidelines, and promoted the leapfrog development of TCM encephalopathy from scratch to strength, making foundational contributions to TCM and encephalopathy prevention and treatment in China.

[Clinical Practice & Outstanding Contributions] With decades of medical practice, Professor Wang has treated hundreds of thousands of patients with stroke, dementia, and other conditions, with significant clinical efficacy. He has received multiple national awards including the National Science and Technology Progress Award, trained a large number of TCM encephalopathy leaders, and is a truly deserving authority in the field of TCM encephalopathy in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Wang Yongyan serves as Honorary President of the China Academy of Chinese Medical Sciences and Honorary President of the China Association of Chinese Medicine, among other academic positions. He was elected as an Academician of the Chinese Academy of Engineering in 1997, received the title of "National Master of Chinese Medicine" in 2017, and has presided over national-level major projects including the National Key R&D Program. He is an authoritative expert in the field of TCM encephalopathy in China. He has led a series of clinical studies on TCM treatment of stroke and dementia, authored authoritative monographs such as TCM Encephalopathy, led the development of multiple TCM encephalopathy diagnosis and treatment guidelines, and promoted the leapfrog development of TCM encephalopathy from scratch. He has received multiple national awards including the National Science and Technology Progress Award, trained a large number of TCM encephalopathy leaders, and is a pillar of the field of TCM encephalopathy in China.